Presentation Will be Webcast Live and Archived on Company's Website
ROCKVILLE, Md., May 8 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA), a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders, today announced that the company will deliver a corporate presentation on Tuesday, May 13, 2008, at 5:20 p.m. Pacific Time.
The presentation will take place as part of the 2008 Bank of America Healthcare Conference at the Four Seasons, Las Vegas, Nevada. The presentation will be available live on the Vanda Website, where it also will be archived for 30 days.
To access the presentation, log on to http://www.vandapharma.com and click on the Presentations option in the Investor Relations section. Please connect to the website several minutes prior to the start of the live presentation
About Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) is a biopharmaceutical
company focused on the development and commercialization of clinical-stage
product candidates for central nervous system disorders. The company has
three product candidates. Vanda's lead product candidate, Fanapta(TM)
(iloperidone), for which Vanda has recently submitted an NDA to the FDA, is
a compound for the treatment of schizophrenia. Vanda's second product
candidate, tasimelteon (VEC-162), is a compound for the treatment of sleep
and mood disorde
|SOURCE Vanda Pharmaceuticals Inc.|
Copyright©2008 PR Newswire.
All rights reserved